Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 10:25 PM
Study NCT ID:
NCT03564158
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2018-04-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers
Sponsor:
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Rempex 512
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | FED | View |